Neuroscience
Alzheimer's Disease
90%
Oligomer
52%
Stem Cell
36%
Tau Protein
35%
Tauopathy
28%
Neurodegenerative Disorder
27%
In Vitro
22%
Frontotemporal Dementia
16%
Cognitive Disorders
12%
In Vivo
11%
Astrogliosis
9%
Neuronal Death
9%
Astrocyte
9%
Neuronal Activity
8%
Metabolic Pathway
8%
Chaperone
8%
Parkinsonism
8%
Levetiracetam
8%
Neuronal Plasticity
8%
Microtubule
8%
Kinase
8%
Methylene Blue
8%
Memory Disorder
8%
Alloxan
8%
Diethylstilbestrol
8%
Chromosome 17
8%
Entorhinal Cortex
8%
Neurological Disorder
8%
Ganglioside
8%
Amyloid Precursor Protein
8%
NMDA Receptor
8%
Hyperactivity
8%
Encephalopathy
6%
Amyloid
6%
Synapse
6%
Adverse Effect
6%
Heat Shock Protein
6%
Ganglioside GM1
5%
Keyphrases
Neurodegenerative Diseases
19%
Granular tau Oligomer
16%
Neurofibrillary Tangles
16%
Tau Oligomers
16%
Alzheimer's Disease
11%
Microtubule Binding
8%
Traditional Medicinal Herbs
8%
HTau
8%
A152T
8%
Lasagna
8%
Cytoskeletal Organization
8%
Paeonia Suffruticosa
8%
Brain Aging
8%
Anti-aggregation
8%
Therapeutic Potential
8%
Early Signs
8%
Oscillation Technique
8%
Binding Capacity
8%
Dimer Order
8%
Higher-order Oligomers
8%
Imaging in Liquid
8%
Bank Data
8%
Drug Target
8%
Age-related Illnesses
8%
Tau Aggregation
8%
P301L
8%
Hippocampal Network
8%
Aggregation Intermediates
8%
Tau Pathology
8%
Protein tau
8%
Tau Post-translational Modification
8%
1,2-Dihydroxybenzene
8%
Arctic mutation
8%
2D/3D Modeling
8%
Neuronal Hyperactivity
8%
FTDP-17
6%
Biochemistry, Genetics and Molecular Biology
Tau
100%
Tau Protein
32%
Induced Pluripotent Stem Cell
19%
Neurofibrillary Tangle
19%
Transgenic Mouse
17%
Clinical Trial
13%
Amyloid Precursor Protein
13%
Wild Type
12%
Mouse
10%
Chromosome 17
9%
Oligomerization
8%
Cysteine
8%
Methylene Blue
8%
Protein Metabolism
8%
Capping Phenomenon
8%
Posttranslational Modification
8%
Sex Difference
8%
Human Induced Pluripotent Stem Cell
8%
